Pelthos Therapeutics Inc.
PTHS
- Revenue · TTM
- $43.3MFour comparable prior quarters required for growth
- Gross profit · TTM
- $28.7MFour comparable prior quarters required for growth66.2% margin
- Operating income · TTM
- $-57.8MFour comparable prior quarters required for growth-133.4% margin
- Free cash flow · TTM
- $-35.4MFour comparable prior quarters required for growth
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Operating metrics
The measures behind the business.
No operating metrics are currently published for this company.
Revenue mix
What the company sells, and where.
Revenue by product
Yearly · USD
Stacked periods reconcile exactly to reported revenue. Periods with missing or overlapping categories are left blank.
Values & sources
| Period | Period end | USD | Source |
|---|---|---|---|
| Net Product · FY 25 | 2025-12-31 | 16,206,000 | 0001919246-26-000013 |
| License And Collaboration · FY 25 | 2025-12-31 | 589,000 | 0001919246-26-000013 |
Revenue by segment
Yearly · USD
Stacked periods reconcile exactly to reported revenue. Periods with missing or overlapping categories are left blank.
Values & sources
| Period | Period end | USD | Source |
|---|---|---|---|
| Research And Development Operations · FY 25 | 2025-12-31 | 589,000 | 0001919246-26-000013 |
| Commercial Operations · FY 25 | 2025-12-31 | 16,206,000 | 0001919246-26-000013 |
Income statement
From revenue to profit.
Cash flow
Cash generated and cash spent.
Balance sheet
What the company owns and what it owes.
Financial statements
Every published field, with exact amounts and disclosure sources.
View full financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15,603,000USD | 10,906,000USD | 9,389,000USD | 7,406,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 3,610,000USD | 1,673,000USD | 4,390,000USD | 4,975,000USD | — | 0USD | — | 0USD |
| Gross Profit | 11,993,000USD | 9,233,000USD | 4,999,000USD | 2,431,000USD | — | 0USD | — | 0USD |
| Research Development | 600,000USD | 186,000USD | 374,000USD | 145,000USD | 514,814USD | 194,298USD | 285,236USD | 414,639USD |
| Selling General Administrative | 27,673,000USD | 21,104,000USD | 12,888,000USD | 12,036,000USD | 2,715,609USD | 1,639,679USD | 1,539,812USD | 1,633,694USD |
| Total Operating Expenses | 29,316,000USD | 22,321,000USD | 17,002,000USD | 17,793,000USD | 3,230,423USD | 1,833,977USD | 1,825,048USD | 2,048,333USD |
| Operating Income | -17,323,000USD | -13,088,000USD | -12,003,000USD | -15,362,000USD | -3,230,423USD | -1,833,977USD | -1,825,048USD | -2,048,333USD |
| Total Other Income Expense Net | -6,094,000USD | -11,985,000USD | -16,583,000USD | -1,341,000USD | -218,516USD | -133,634USD | -101,686USD | 353,678USD |
| Interest Expense | 2,389,000USD | 2,353,000USD | 1,314,000USD | 1,346,000USD | 218,516USD | 133,634USD | 107,966USD | 39,019USD |
| Income Before Tax | -23,417,000USD | -25,073,000USD | -28,586,000USD | -16,703,000USD | -3,448,939USD | -1,967,611USD | -1,926,734USD | -1,694,655USD |
| Income Tax Expense | 0USD | 0USD | -6,922,000USD | -465,000USD | — | — | — | — |
| Net Income | -23,417,000USD | -25,073,000USD | -21,664,000USD | -16,238,000USD | -3,448,939USD | -1,967,611USD | -1,926,734USD | -1,694,655USD |
| Selling And Marketing Expenses | — | — | 2,863,000USD | 4,933,000USD | — | — | — | — |
| Interest Income | — | — | 0USD | 5,000USD | 0USD | — | — | 393,000USD |
| Net Interest Income | — | — | -1,314,000USD | -1,341,000USD | -218,516USD | -133,634USD | -107,966USD | -39,019USD |
| Tax Provision | — | — | -6,922,000USD | -465,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | — | -21,664,000USD | -16,238,000USD | -3,448,939USD | -1,967,611USD | -1,926,734USD | -1,694,655USD |
| Ebit | — | — | -27,272,000USD | -15,357,000USD | — | — | — | — |
| Ebitda | — | — | -26,055,000USD | -14,678,000USD | -3,230,423USD | -1,833,977USD | -1,818,768USD | -1,655,636USD |
| Depreciation And Amortization | — | — | 1,217,000USD | 679,000USD | — | — | — | — |
| Reconciled Depreciation | — | — | 1,217,000USD | 2,093,000USD | — | 0USD | — | 0USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 16,795,000USD | 0USD | 0USD | 0USD | 0USD | 199,934USD |
| Cost Of Revenue | 9,365,000USD | 0USD | — | — | — | — |
| Gross Profit | 7,430,000USD | 0USD | — | — | — | 199,934USD |
| Research Development | 1,228,000USD | 1,179,436USD | 2,579,418USD | 391,730USD | 209,047USD | 138,585USD |
| Selling General Administrative | 29,280,000USD | 6,392,013USD | 4,282,866USD | 1,926,429USD | 629,949USD | — |
| Selling And Marketing Expenses | 7,796,000USD | — | — | — | — | — |
| Unclassified Operating Expenses | 1,556,000USD | — | — | — | — | 1,415,216USD |
| Total Operating Expenses | 39,860,000USD | 7,571,449USD | 6,862,284USD | 2,318,159USD | 838,996USD | 1,553,801USD |
| Operating Income | -32,430,000USD | -7,571,449USD | -6,862,284USD | -2,318,159USD | -838,996USD | -1,353,867USD |
| Interest Income | 5,000USD | 402,000USD | — | — | — | — |
| Interest Expense | 3,012,000USD | 786,393USD | 518,509USD | 140,430USD | 253USD | 1,676USD |
| Net Interest Income | -3,007,000USD | -786,393USD | -518,509USD | -140,430USD | -253USD | — |
| Income Before Tax | -50,706,000USD | -7,955,338USD | -7,380,793USD | -2,458,589USD | -595,387USD | -660,584USD |
| Income Tax Expense | -7,387,000USD | — | — | — | — | — |
| Tax Provision | -7,387,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Net Income | -43,319,000USD | -7,955,338USD | -7,380,793USD | -2,458,589USD | -595,387USD | -660,584USD |
| Net Income From Continuing Ops | -43,319,000USD | -7,955,338USD | -7,380,793USD | -2,458,589USD | -595,387USD | — |
| Ebit | -47,694,000USD | — | — | — | — | — |
| Ebitda | -45,409,000USD | -7,168,945USD | -6,862,284USD | -2,318,159USD | -595,134USD | -658,908USD |
| Depreciation And Amortization | 2,285,000USD | — | — | — | — | — |
| Reconciled Depreciation | 2,285,000USD | 0USD | — | — | — | — |
| Total Other Income Expense Net | -18,276,000USD | -383,889USD | -518,509USD | -140,430USD | 243,609USD | 693,283USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 137,356,000USD | 145,378,000USD | 130,396,999USD | 126,433,000USD | 822,850USD | 911,179USD | 1,369,143USD | 2,139,888USD |
| Cash And Equivalents | 24,192,000USD | 31,976,000USD | — | — | — | — | — | — |
| Total Current Assets | 63,356,000USD | 69,801,000USD | 52,699,000USD | 49,050,000USD | 822,850USD | 911,179USD | 1,369,143USD | 2,139,888USD |
| Other Current Assets | 2,842,000USD | 2,457,000USD | 2,244,000USD | 2,713,000USD | 723,278USD | 739,462USD | 815,300USD | 844,585USD |
| Total Liabilities | 138,857,000USD | 126,112,000USD | — | — | — | — | — | — |
| Total Current Liabilities | 31,959,000USD | 25,003,000USD | 25,993,000USD | 24,768,000USD | 7,317,145USD | 5,107,013USD | 4,083,197USD | 3,567,382USD |
| Other Current Liabilities | 20,745,000USD | 3,403,000USD | — | — | — | — | — | — |
| Total Stockholder Equity | -1,501,000USD | 19,266,000USD | 38,881,000USD | 58,253,000USD | -6,494,295USD | -4,195,834USD | -2,714,054USD | -1,427,494USD |
| Total Equity Including Noncontrolling Interest | -1,501,000USD | 19,266,000USD | — | — | — | — | — | — |
| Deferred Revenue | 729,000USD | 978,000USD | — | — | — | — | — | — |
| Deferred Revenue Non Current | 1,093,000USD | 1,027,000USD | — | — | — | — | — | — |
| Net Receivables | 14,482,000USD | 11,700,000USD | 8,858,000USD | 7,988,000USD | 40,400USD | 40,400USD | 40,400USD | 40,400USD |
| Inventory | 21,472,000USD | 23,418,000USD | 23,574,000USD | 24,096,000USD | — | — | 0USD | — |
| Property Plant Equipment Net | 11,922,000USD | 12,456,000USD | 12,836,000USD | 13,526,000USD | — | — | 0USD | — |
| Goodwill | 24,681,000USD | 24,681,000USD | — | — | — | — | — | — |
| Accounts Payable | 5,853,000USD | 6,147,000USD | 2,986,000USD | 5,666,000USD | 4,988,822USD | 2,603,605USD | 1,897,127USD | 1,279,487USD |
| Short Term Debt | 645,000USD | 640,000USD | 635,000USD | 631,000USD | 2,304,687USD | 2,503,408USD | 2,186,070USD | 2,287,587USD |
| Common Stock | 0USD | 0USD | — | — | 67USD | 621USD | 613USD | 583USD |
| Retained Earnings | -113,284,000USD | -89,867,000USD | -64,794,000USD | -43,130,000USD | -26,891,537USD | -23,442,598USD | -21,474,987USD | -19,548,253USD |
| Accumulated Other Comprehensive Income | 2,078,000USD | 2,188,000USD | — | — | — | — | — | — |
| Other Non Current Liabilities | — | 31,955,000USD | — | — | — | — | — | — |
| Intangible Assets | — | — | 39,470,000USD | 32,521,000USD | — | — | — | — |
| Total Liab | — | — | 91,516,000USD | 68,180,000USD | 7,317,145USD | 5,107,013USD | 4,083,197USD | 3,567,382USD |
| Other Current Liab | — | — | 21,406,000USD | 17,452,000USD | 23,636USD | — | — | 308USD |
| Capital Stock | — | — | 0USD | 0USD | 67USD | 621USD | 613USD | 583USD |
| Good Will | — | — | 24,681,000USD | 30,625,000USD | — | — | 0USD | — |
| Cash | — | — | 18,023,000USD | 14,253,000USD | 59,172USD | 131,317USD | 513,443USD | 1,254,903USD |
| Cash And Short Term Investments | — | — | 18,023,000USD | 14,253,000USD | 59,172USD | 131,317USD | 513,443USD | 1,254,903USD |
| Current Deferred Revenue | — | — | 966,000USD | 1,018,999USD | — | — | — | — |
| Net Debt | — | — | 16,805,000USD | -10,773,000USD | 2,245,515USD | 2,372,091USD | 1,672,627USD | 1,032,684USD |
| Short Long Term Debt Total | — | — | 34,828,000USD | 3,480,000USD | 2,304,687USD | 2,503,408USD | 2,186,070USD | 2,287,587USD |
| Long Term Debt | — | — | 31,441,000USD | — | — | — | — | — |
| Property Plant Equipment Gross | — | — | 13,768,000USD | 13,914,000USD | — | — | 0USD | — |
| Common Stock Shares Outstanding | — | — | 3,154,538shares | 640,518shares | 640,518shares | 612,792shares | 596,011shares | 579,229shares |
| Non Current Assets Total | — | — | 77,698,000USD | 77,383,000USD | 0USD | 0USD | 0USD | 0USD |
| Non Current Liabilities Total | — | — | 65,523,000USD | 43,412,000USD | 0USD | 0USD | 0USD | 0USD |
| Non Current Liabilities Other | — | — | 30,050,000USD | 26,175,000USD | — | — | — | — |
| Non Currrent Assets Other | — | — | 711,000USD | 711,000USD | — | — | — | — |
| Net Working Capital | — | — | 27,417,000USD | 24,993,000USD | -6,494,295USD | -4,195,834USD | -2,714,054USD | -1,427,494USD |
| Unclassified Non Current Liabilities | — | — | 4,032,000USD | 17,237,000USD | — | — | — | — |
| Unclassified Equity | — | — | 103,675,000USD | 101,383,000USD | 20,397,108USD | 19,245,522USD | 18,759,707USD | 18,119,593USD |
| Short Long Term Debt | — | — | — | — | 2,304,687USD | 2,503,408USD | 2,186,070USD | 2,287,587USD |
| Unclassified Current Liabilities | — | — | — | — | -2,304,687USD | -2,503,408USD | -2,186,070USD | -2,287,587USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 130,396,999USD | 1,369,143USD | 96,391USD | 55,074USD | 0USD | — |
| Intangible Assets | 39,470,000USD | — | — | — | — | — |
| Other Current Assets | 2,244,000USD | 815,300USD | — | — | — | — |
| Total Liab | 91,516,000USD | 4,083,197USD | 6,540,943USD | 3,761,611USD | 3,680,267USD | — |
| Total Stockholder Equity | 38,881,000USD | -2,714,054USD | -6,444,552USD | -3,706,537USD | -3,680,267USD | — |
| Other Current Liab | 21,406,000USD | — | 651,333USD | 227,261USD | — | — |
| Capital Stock | 0USD | 613USD | 451USD | 171USD | 0USD | — |
| Retained Earnings | -64,794,000USD | -21,474,987USD | -13,519,649USD | -6,138,856USD | -3,680,267USD | — |
| Good Will | 24,681,000USD | 0USD | — | — | — | — |
| Cash | 18,023,000USD | 513,443USD | 96,391USD | 55,074USD | 0USD | — |
| Cash And Short Term Investments | 18,023,000USD | 513,443USD | 96,391USD | 55,074USD | — | — |
| Total Current Assets | 52,699,000USD | 1,369,143USD | 96,391USD | 55,074USD | 0USD | — |
| Total Current Liabilities | 25,993,000USD | 4,083,197USD | 6,540,943USD | 3,761,611USD | 2,580,317USD | — |
| Current Deferred Revenue | 966,000USD | — | — | — | — | — |
| Net Debt | 16,805,000USD | 1,672,627USD | 1,172,294USD | 485,356USD | — | — |
| Short Term Debt | 635,000USD | 2,186,070USD | 1,268,685USD | 540,430USD | — | — |
| Short Long Term Debt Total | 34,828,000USD | 2,186,070USD | 1,268,685USD | 540,430USD | — | — |
| Long Term Debt | 31,441,000USD | — | — | — | — | — |
| Net Receivables | 8,858,000USD | 40,400USD | — | — | — | — |
| Inventory | 23,574,000USD | 0USD | — | — | — | — |
| Accounts Payable | 2,986,000USD | 1,897,127USD | 4,620,925USD | 2,993,920USD | 2,580,317USD | — |
| Property Plant Equipment Net | 12,836,000USD | 0USD | — | — | — | — |
| Property Plant Equipment Gross | 13,768,000USD | 0USD | — | — | — | — |
| Common Stock Shares Outstanding | 1,880,498shares | 587,620shares | 576,752shares | 576,752shares | 576,752shares | 576,752shares |
| Non Current Assets Total | 77,698,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Non Current Liabilities Total | 65,523,000USD | 0USD | 0USD | 0USD | 1,099,950USD | — |
| Non Current Liabilities Other | 30,050,000USD | — | — | — | — | — |
| Non Currrent Assets Other | 711,000USD | — | — | — | — | — |
| Net Working Capital | 27,417,000USD | -2,714,054USD | -6,444,552USD | -3,706,537USD | -2,580,317USD | — |
| Unclassified Non Current Liabilities | 4,032,000USD | — | — | — | 1,099,950USD | — |
| Unclassified Equity | 103,675,000USD | 18,759,707USD | 7,074,255USD | 2,432,037USD | — | — |
| Common Stock | — | 613USD | 391USD | 111USD | — | — |
| Short Long Term Debt | — | 2,186,070USD | 1,268,685USD | 540,430USD | — | — |
| Unclassified Current Liabilities | — | -2,186,070USD | -1,268,685USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,821,000USD |
| Stock Based Compensation | 4,668,000USD |
| Change To Account Receivables | -5,624,000USD |
| Change To Inventory | 1,374,000USD |
| Change To Liabilities | 9,221,000USD |
| Change In Working Capital | -1,427,000USD |
| Operating Cash Flow | -20,790,000USD |
| Capital Expenditures | -196,000USD |
| Investing Cash Flow | -196,000USD |
| Financing Cash Flow | 27,523,000USD |
| Change In Cash | 6,537,000USD |
| End Cash Flow | 24,560,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 1,500,000USD | 1,217,000USD | 1,142,000USD | — | 0USD | — | — | — |
| Stock Based Compensation | 1,908,000USD | 1,799,000USD | 2,762,683USD | 413,486USD | 485,831USD | 530,422USD | 517,343USD | 458,978USD |
| Change To Account Receivables | -2,842,000USD | -870,000USD | -7,940,000USD | — | 0USD | — | — | — |
| Change To Inventory | 156,000USD | 393,000USD | — | — | 0USD | — | — | — |
| Change To Liabilities | 1,253,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | 475,000USD | -4,217,000USD | -5,033,071USD | 2,423,630USD | 755,441USD | 649,961USD | 1,352,189USD | -1,639,774USD |
| Operating Cash Flow | -13,126,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -194,000USD | -99,000USD | 0USD | -5USD | 0USD | 0USD | 0USD | 0USD |
| Investing Cash Flow | -194,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 27,523,000USD | — | — | — | — | — | — | — |
| Change In Cash | 14,203,000USD | 3,770,000USD | 14,121,683USD | -72,145USD | -382,126USD | -741,460USD | -1,150,195USD | -1,365,131USD |
| End Cash Flow | 32,226,000USD | — | — | — | — | — | — | — |
| Net Income | — | -21,664,000USD | -16,238,000USD | -3,448,939USD | -1,967,611USD | -1,926,734USD | -1,694,655USD | -1,771,619USD |
| Other Non Cash Items | — | 18,412,000USD | 4,870,342USD | 164,678USD | 94,213USD | 76,087USD | -352,788USD | 0USD |
| Total Cash From Operating Activities | — | -6,252,000USD | -15,258,729USD | -447,145USD | -632,126USD | -670,264USD | -177,911USD | -2,952,415USD |
| Free Cash Flow | — | -6,351,000USD | -15,258,730USD | -447,145USD | -632,126USD | -670,264USD | -177,911USD | -2,952,415USD |
| Total Cashflows From Investing Activities | — | -7,997,000USD | 2,761,000USD | — | — | — | — | — |
| Net Borrowings | — | -9,486,000USD | 26,607,000USD | 375,000USD | 250,000USD | -153,816USD | -897,527USD | — |
| Total Cash From Financing Activities | — | 18,019,000USD | 26,692,000USD | 375,000USD | 250,000USD | -71,196USD | -972,284USD | 1,587,284USD |
| Sale Purchase Of Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | -75,000USD | 0USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 82,620USD | 0USD | 0USD |
| Begin Period Cash Flow | — | 14,253,000USD | 131,317USD | 131,317USD | 513,443USD | 1,254,903USD | 2,405,098USD | 3,770,229USD |
| End Period Cash Flow | — | 18,023,000USD | 14,253,000USD | 59,172USD | 131,317USD | 513,443USD | 1,254,903USD | 2,405,098USD |
| Unclassified Operating Cash Flow | — | -1,799,000USD | -2,762,683USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | -7,898,000USD | 2,761,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 27,505,000USD | — | — | — | — | — | 1,587,284USD |
| Source | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -43,319,000USD | -7,955,338USD | -7,380,793USD | -2,458,589USD | -595,387USD |
| Depreciation | 2,359,000USD | 0USD | — | — | — |
| Stock Based Compensation | 5,461,000USD | 1,799,295USD | 1,733,233USD | 110,146USD | 0USD |
| Other Non Cash Items | 24,441,000USD | 328,929USD | 2,615,452USD | 140,430USD | — |
| Change To Account Receivables | -8,810,000USD | -45,786USD | — | — | — |
| Change To Inventory | 1,778,000USD | 0USD | — | — | — |
| Change In Working Capital | -6,071,000USD | 34,631USD | 2,051,077USD | 640,864USD | -755,831USD |
| Total Cash From Operating Activities | -22,590,000USD | -5,792,483USD | -981,031USD | -1,567,149USD | -1,593,011USD |
| Capital Expenditures | -99,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -22,689,000USD | -5,792,483USD | -981,031USD | -1,567,149USD | -1,593,011USD |
| Total Cashflows From Investing Activities | -5,236,000USD | — | — | — | — |
| Net Borrowings | 17,746,000USD | 321,427USD | 766,936USD | 400,000USD | 0USD |
| Total Cash From Financing Activities | 45,336,000USD | 6,209,535USD | 1,022,348USD | 1,622,223USD | 1,593,011USD |
| Sale Purchase Of Stock | 0USD | -166,512USD | 0USD | — | — |
| Issuance Of Capital Stock | 0USD | 6,054,620USD | 255,412USD | 0USD | — |
| Change In Cash | 17,509,557USD | 417,052USD | 41,317USD | 55,074USD | 0USD |
| Begin Period Cash Flow | 513,443USD | 96,391USD | 55,074USD | 0USD | 0USD |
| End Period Cash Flow | 18,023,000USD | 513,443USD | 96,391USD | 55,074USD | 0USD |
| Unclassified Operating Cash Flow | -5,461,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | -5,137,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | 27,590,000USD | 6,054,620USD | — | — | 1,593,011USD |
| Other Cashflows From Financing Activities | — | — | — | 1,222,223USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. TTM requires four complete quarters. Missing values are not zero. Charts use rounded labels; expand values and sources for exact amounts. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.